India's cement sector faces a subdued start to FY27, with extended heat and water scarcity dampening construction despite a delayed monsoon...

Motilal Oswal has initiated coverage on Tata Capital with a 'Neutral' rating and a target price of Rs 390, implying an 8% upside from curre...

Nomura has named Bharti Airtel its top telecom pick, raising its target price to Rs 2,355 and calling it an 'ARPU compounder'. The brokerag...

Mahanagar Gas shares have surged on government's push for piped natural gas adoption, aiming for a 20% customer base increase. This move is...

Espire Hospitality has achieved a landmark financial year 2026, reporting Rs 141 crore in revenue, a 17% increase, and Rs 8 crore in profit...

During the second half of FY26, PayU India also exited certain "negative margin portfolios", impacting its sequential revenue growth. In th...

Indian auto ancillaries witnessed robust revenue growth of 12.5% in FY26, driven by strong volumes and a better product mix. While EBITDA a...

ITC's business with major shareholder British American Tobacco (BAT) saw a 10% expansion in sales to Rs 1,587 crore in FY26, though dividen...

India faces mounting vulnerability due to its soaring dependence on imported crude oil, now exceeding 90%. A recent EY report urges augment...

India's fiscal deficit is expected to remain under control in FY27, thanks to robust nominal GDP growth driven by higher inflation, accordi...

ITC Chairman and Managing Director Sanjiv Puri's total pay saw a 6.8% dip to Rs 23.91 crore in FY26, primarily due to lower performance bon...

Laurus Labs' stock has surged 30% on robust FY26 results, fueled by a booming contract manufacturing business and improved product mix. The...

Indian contract manufacturers are poised for significant growth as global pharmaceutical giants diversify away from China. Companies like S...

India’s audit market in FY26 remained dominated by large firms, with EY, KPMG and Deloitte leading by audit volume and market capitalisatio...

Affordable housing finance companies are poised for a growth rebound from FY27, according to Kotak Institutional Securities. After a subdue...

Honasa Consumer, parent of Mamaearth, is acquiring a 58% stake in nutraceuticals firm Fluence Pharma for Rs 135 crore, marking its entry in...

India's largest drugmaker, Sun Pharma, is set to acquire Mumbai-based Innovcare Lifesciences for approximately $28.7 million in an all-cash...